Ending a decades-long wait, the US Food and Drug Administration (FDA) today approved the Amplatzer PFO Occluder device (St. Jude Medical) for recurrent stroke prevention in patients with a patent ...
With the approval of the AMPLATZER PFO Occluder, patients in the U.S. with a PFO who have suffered an ischemic stroke – a stroke resulting from blockages in the blood supply to the brain – will now ...
St. Jude Medical’s (STJ) Amplatzer PFO Occluder has finally returned to the US market after a decade in the wilderness. The device, used to plug a hole in the heart and thereby prevent recurrent ...
Medical devices major, St. Jude Medical Inc. (STJ), presented additional data from the RESPECT clinical trail at the American Stroke Association’s International Stroke Conference 2013. The trial is ...
St. Jude Medical’s stroke-fighting heart occluder picked up FDA approval on Friday. The device had previously been available in the U.S. under a humanitarian device exemption, but was voluntarily ...
LONDON, UK / ACCESSWIRE / October 31, 2016 / Active Wall St. blog coverage looks at the headline from St. Jude Medical Inc. (NYSE: STJ). The company announced on October 28th, 2016, that the U.S. Food ...
- Abbott's Talisman system seals an opening in the heart known as a "patent foramen ovale" (PFO) to prevent blood clots from passing from the right to the left side of the heart and on to the brain, ...
Two controversial trials testing PFO closure with the Amplatzer PFO Occluder (St. Jude Medical) in patients with cryptogenic stroke, first presented last fall at the TCT meeting, have now been ...
“Percutaneous PFO closure with the investigational Amplatzer PFO Occluder device for secondary prevention of thromboembolism showed no significant reduction in ischemic and bleeding events compared ...
A practice advisory update from the American Academy of Neurology (AAN) warns against routinely offering percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic ischemic stroke ...
MINNEAPOLIS, Minnesota — The now publicly held AGA Medical has won Chinese approval for three of its devices and will begin selling there through its distributor, Abbott Laboratories. A broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback